POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No91/2013
Date of issue:2013-07-04
Short name of the issuer
SOPHARMA AD
Subject
Current report 91 Lavena AD above 5%
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") announces that on 18 June 2013 the Company bought 4 039 from the capital increase of Lavena AD. After this transaction, the share of Sopharma AD in the capital of Lavena AD increased to 5.18%.
Annexes
FileDescription
Current report 91 Lavena AD above 5%.docCurrent report 91 Lavena AD above 5%
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2013-07-04Ognian DonevExecutive Director